drugset / Trial / NCT00252499

Insulin Resistance in Non-alcoholic Fatty Liver Disease

NCT00252499

Terminated 13 enrolled US Department of Veterans Affairs
RandomizedParallel-groupTriple-blindBasic science

Summary

The purpose of this study is to determine whether nonalcoholic fatty liver disease (NAFLD) is associated with altered peripheral and hepatic insulin sensitivity and to investigate potential mechanisms underlying insulin resistance in NAFLD by determining associations between hepatic and peripheral insulin sensitivity, hepatic steatosis, dyslipidemia, inflammatory cytokines, glucose metabolism, beta-cell function and body fat distribution.

Timeline

Start
2005-10
Primary completion
2010-08
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenofibrate Small molecule 200 mg Oral
Subject Rosiglitazone Small molecule 4 mg Oral

Indications